This finding is consistent with the rheostat model of MITF developed from scRNA-Seq data on metastatic tumors and melanoma cell lines; it postulates that MITF has intermediate activity in normal melanocytes, is over-activated in hyperpigmented melanomas cells and is repressed in de-differentiated melanomas67. Here, MITF is linked to metastatic neoplasm.